MetaVia Inc. is trading at $1.62 (5.3% down) in after-hours trading. * The stock declined from a regular-session close of $1.71, amidst a broader market downturn and a hawkish stance from the Federal Reserve. * On June 17, 2026, MetaVia Inc. announced that its CEO will participate in a fireside chat at the Life Sciences Virtual Investor Forum on June 24, 2026, to highlight its pipeline of novel obesity and metabolic therapies. * The price action appears to reflect general market sentiment and after-hours liquidity rather than any negative specific company development.